Previous studies have evidenced MPPED2 downregulation also in neuroblastoma [10], cervical cancer [11], oral squamous carcinoma [12] and thyroid cancer [13], indicating that its tumor suppressor activity is not confined to few neoplastic histotypes. This evidence concerns the gene MPPED2 and thyroid cancer.